title: Advances in Urate-Lowering Therapy: Time to Revisit High-Dose Febuxostat.
authors.affiliation: Department of Medicine, University of Connecticut Health Center, Meriden, CT.
authors.forename: Aryeh M
authors.initials: AM
authors.lastname: Abeles
mesh_terms: D017277:Drug Approval; D004359:Drug Therapy, Combination; D000069465:Febuxostat / Q000627:therapeutic use*; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D006074:Gout Suppressants; D000069465:Febuxostat